Concepedia

Hannah Rinehardt

HR

Statistics

Publications

8

Citations

163

H-Index

8

Active since

2017

Affiliations

The Ohio State University(Current)

Nationwide Children's Hospital

Cincinnati Children's Hospital Medical Center

Seattle Children's Hospital

University of Utah

Hannah Rinehardt is an author at The Ohio State University specializing in cystic fibrosis, surgical oncology, and life sciences.

ORCID

Publications per year

2017–2024

8

Publications

8

Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways

Divya Subramonian, Nikki Phanhthilath, Hannah Rinehardt et al. · British Journal of Cancer · 2020 · 54 citations · Full text

, , +12

Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages

Chandra L. Shrestha, Kaivon Assani, Hannah Rinehardt et al. · PLoS ONE · 2017 · 33 citations · Full text

, , +17

Appendectomy Versus Observation for Appendicitis in Neutropenic Children With Cancer

Benjamin T. Many, Timothy B. Lautz, Sarah Dobrozsi et al. · PEDIATRICS · 2021 · 16 citations · Full text

, , +16

Management and Outcomes of Wilms Tumor With Suprarenal Intravascular Extension

Bindi Naik‐Mathuria, Alan F. Utria, Peter F. Ehrlich et al. · Annals of Surgery · 2023 · 15 citations · Full text

, , +13

AR-13 reduces antibiotic-resistant bacterial burden in cystic fibrosis phagocytes and improves cystic fibrosis transmembrane conductance regulator function

Kaivon Assani, Chandra L. Shrestha, Hannah Rinehardt et al. · Journal of Cystic Fibrosis · 2018 · 14 citations · Full text

, , +13

1–5 of 8